CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-28 | Inbar Galia See "Remarks" | Option exercise · Restricted Share Units | −4,828 | 9,657 | ||
| 2022-02-28 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +21,682 | 73,098.51 | ||
| 2022-02-28 | Fridriksdottir Hafrun Executive VP, Global R&D | Sale | −7,590 | $8.14 | $62K | 65,508.51 |
| 2022-02-28 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −21,682 | 43,366 | ||
| 2022-02-28 | Drape Eric Executive VP Global Operations | Option exercise | +19,514 | 55,627 | ||
| 2022-02-28 | Drape Eric Executive VP Global Operations | Sale | −9,797 | $8.14 | $80K | 45,830 |
| 2022-02-28 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −19,514 | 39,029 | ||
| 2022-02-28 | Dethlefs Sven EVP, North America Commercial | Option exercise | +17,346 | 104,319 | ||
| 2022-02-28 | Dethlefs Sven EVP, North America Commercial | Sale | −4,862 | $8.14 | $40K | 99,457 |
| 2022-02-28 | Dethlefs Sven EVP, North America Commercial | Option exercise · Restricted Share Units | −17,346 | 34,692 | ||
| 2022-02-28 | Daniell Richard Exec. VP, European Commercial | Option exercise | +20,598 | 40,878 | ||
| 2022-02-28 | Daniell Richard Exec. VP, European Commercial | Sale | −20,598 | $8.14 | $168K | 20,280 |
| 2022-02-28 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −20,598 | 41,197 | ||
| 2022-02-13 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +6,629 | 25,059 | ||
| 2022-02-13 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −6,629 | 13,259 | ||
| 2022-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +12,538 | 15,512.39 | ||
| 2022-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −6,110 | $9.06 | $55K | 9,402.39 |
| 2022-02-09 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −12,538 | 0 | ||
| 2022-02-09 | Schultz Kare President and CEO | Option exercise | +26,867 | 1,067,449 | ||
| 2022-02-09 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −26,867 | 0 |
Page 41 of 76 · 1,517 trades